Biosafety during a pandemic: shared resource laboratories rise to the challenge.

Szczegóły
Abstrakt

Tytuł:: Biosafety during a pandemic: shared resource laboratories rise to the challenge.
Autorzy:: Aspland AM; Sydney Cytometry Core Research Facility, Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
Douagi I; Flow Cytometry Section, Research Technologies Branch, NIAID, NIH, Bethesda, Maryland, USA.
Filby A; Innovation, Methodology and Application Research Theme, Newcastle University, Newcastle upon Tyne, UK.
Jellison ER; Department of Immunology, UCONN School of Medicine, Farmington, Connecticut, USA.
Martinez L; Biotechnology Programme, Flow Cytometry Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Shinko D; Sydney Cytometry Core Research Facility, Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
Smith AL; Sydney Cytometry Core Research Facility, Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
Tang VA; Faculty of Medicine, Department of Biochemistry, Microbiology, and Immunology, Flow Cytometry and Virometry Core Facility, University of Ottawa, Ottawa, Ontario, Canada.
Thornton S; Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
Źródło:: Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2021 Jan; Vol. 99 (1), pp. 68-80. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Review
Język:: English
Imprint Name(s):: Original Publication: Hoboken, N.J. : Wiley-Liss, c2002-
MeSH Terms:: COVID-19/*epidemiology
Containment of Biohazards/*trends
Laboratories/*trends
COVID-19/prevention & control ; COVID-19/transmission ; Containment of Biohazards/standards ; Flow Cytometry ; Humans ; Laboratories/standards ; Risk Assessment/standards ; Risk Assessment/trends
References:: Am J Infect Control. 1997 Aug;25(4):335-9. (PMID: 9276546)
Emerg Infect Dis. 2020 Jul;26(7):1631-1633. (PMID: 32243255)
Clin Microbiol Rev. 1997 Oct;10(4):597-610. (PMID: 9336664)
Mutat Res. 2007 Nov-Dec;636(1-3):178-242. (PMID: 17980649)
Nature. 2020 May;581(7809):465-469. (PMID: 32235945)
J Infect. 2020 Sep;81(3):e90-e92. (PMID: 32574567)
Cytometry A. 2021 Jan;99(1):33-41. (PMID: 33190383)
N Engl J Med. 2020 Apr 16;382(16):1564-1567. (PMID: 32182409)
J Virol Methods. 2004 Oct;121(1):85-91. (PMID: 15350737)
Ann Intern Med. 2020 Nov 17;173(10):853-854. (PMID: 32678685)
Cytometry. 1999 Oct 15;38(5):195-200. (PMID: 10516605)
Biopreserv Biobank. 2013 Aug;11(4):229-34. (PMID: 24845590)
Cytometry A. 2014 May;85(5):434-53. (PMID: 24634405)
Methods Mol Biol. 2019;1989:159-192. (PMID: 31077106)
Cytometry A. 2020 Jul;97(7):674-680. (PMID: 32488957)
Water Environ Res. 2018 Feb 1;90(2):110-121. (PMID: 28646570)
Nat Med. 2020 Aug;26(8):1183-1192. (PMID: 32770165)
J Hosp Infect. 2021 Jan;107:45-49. (PMID: 32991941)
J Hosp Infect. 2020 Oct;106(2):226-231. (PMID: 32652214)
Appl Environ Microbiol. 2011 Oct;77(20):7289-95. (PMID: 21856830)
Viruses. 2020 Jun 08;12(6):. (PMID: 32521706)
J Am Soc Cytopathol. 2020 May - Jun;9(3):202-211. (PMID: 32284276)
Cytometry A. 2003 Dec;56(2):113-9. (PMID: 14608639)
Crit Care. 2020 Aug 12;24(1):495. (PMID: 32787909)
Phys Fluids (1994). 2020 Sep 1;32(9):091701. (PMID: 32952381)
Med Microbiol Immunol. 2005 Jan;194(1-2):1-6. (PMID: 15118911)
Cytometry A. 2019 Feb;95(2):173-182. (PMID: 30561906)
J Hosp Infect. 2020 Mar;104(3):246-251. (PMID: 32035997)
Cytometry A. 2011 Dec;79(12):1000-8. (PMID: 22052694)
Gates Open Res. 2018 Feb 27;1:2. (PMID: 29608197)
Cytometry A. 2021 Jan;99(1):42-50. (PMID: 33175460)
Indoor Air. 2007 Feb;17(1):2-18. (PMID: 17257148)
Viruses. 2020 Jun 06;12(6):. (PMID: 32517266)
J Infect Dis. 2020 Oct 1;222(9):1462-1467. (PMID: 32798217)
Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164. (PMID: 18068815)
Water Res. 2002 Nov;36(18):4433-44. (PMID: 12418646)
J Immunol Methods. 1993 Apr 2;160(2):215-8. (PMID: 8459108)
Appl Environ Microbiol. 2021 Sep 10;87(19):e0031421. (PMID: 34288702)
MMWR Recomm Rep. 1994 Mar 4;43(RR-3):1-21. (PMID: 7908403)
Emerg Infect Dis. 2019 May;25(5):919-926. (PMID: 30681072)
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163. (PMID: 32356867)
Cytometry A. 2021 Jan;99(1):68-80. (PMID: 33289290)
Am J Infect Control. 2020 Aug;48(8):972-973. (PMID: 32461067)
Nat Commun. 2020 Aug 6;11(1):3910. (PMID: 32764693)
J Infect. 2020 Sep;81(3):357-371. (PMID: 32615199)
Lancet Microbe. 2020 May;1(1):e10. (PMID: 32835322)
J Virol Methods. 2014 Feb;196:50-5. (PMID: 24184086)
Cytometry A. 2017 Nov;91(11):1115-1124. (PMID: 29072808)
J Virol Methods. 2015 Sep 15;222:28-33. (PMID: 25997377)
Lancet. 2020 Jun 27;395(10242):1973-1987. (PMID: 32497510)
J Gen Intern Med. 2020 Sep;35(9):2821-2822. (PMID: 32542495)
JAMA. 2020 May 12;323(18):1843-1844. (PMID: 32159775)
J Clin Microbiol. 2020 Oct 21;58(11):. (PMID: 32839250)
BMJ. 2020 Apr 21;369:m1443. (PMID: 32317267)
Lab Med. 2020 May 6;51(3):239-242. (PMID: 32275309)
Viruses. 2015 Feb 10;7(2):666-79. (PMID: 25674771)
Dermatology. 2006;212 Suppl 1:119-23. (PMID: 16490989)
Am J Public Health. 1990 Apr;80(4):423-7. (PMID: 2316762)
Wellcome Open Res. 2020 Jul 29;5:181. (PMID: 33283055)
Grant Information:: National Institute of Allergy and Infectious Diseases
Contributed Indexing:: Keywords: COVID-19; SARS-CoV-2; biosafety guidelines; cytometry; emerging disease; epidemic; flow cytometry; pandemic; shared resource laboratory (SRL)
Entry Date(s):: Date Created: 20201208 Date Completed: 20210303 Latest Revision: 20220716
Update Code:: 20240104
PubMed Central ID:: PMC7753791
DOI:: 10.1002/cyto.a.24280
PMID:: 33289290
: Czasopismo naukowe

Full Text Finder

Biosafety has always been an important aspect of daily work in any research institution, particularly for cytometry Shared Resources Laboratories (SRLs). SRLs are common-use spaces that facilitate the sharing of knowledge, expertise, and ideas. This sharing inescapably involves contact and interaction of all those within this working environment on a daily basis. The current pandemic caused by SARS-CoV-2 has prompted the re-evaluation of many policies governing the operations of SRLs. Here we identify and review the unique challenges SRLs face in maintaining biosafety standards, highlighting the potential risks associated with not only cytometry instrumentation and samples, but also the people working with them. We propose possible solutions to safety issues raised by the COVID-19 pandemic and provide tools for facilities to adapt to evolving guidelines and future challenges.
(© 2021 International Society for Advancement of Cytometry.)

Informacja